Carregant...
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/180503
Platelet miRNA Biosignature Discriminates between Dementia with Lewy Bodies and Alzheimer’s Disease
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Dementia with Lewy bodies (DLB) is one of the most common causes of degenerative dementia, after Alzheimer's disease (AD), and presents pathological and clinical overlap with both AD and Parkinson's disease (PD). Consequently, only one in three DLB cases is diagnosed correctly. Platelets, previously related to neurodegeneration, contain microRNAs (miRNAs) whose analysis may provide disease biomarkers. Here, we profiled the whole platelet miRNA transcriptome from DLB patients and healthy controls. Differentially expressed miRNAs were further validated in three consecutive studies from 2017 to 2019 enrolling 162 individuals, including DLB, AD, and PD patients, and healthy controls. Results comprised a seven-miRNA biosignature, showing the highest diagnostic potential for the differentiation between DLB and AD. Additionally, compared to controls, two miRNAs were down-regulated in DLB, four miRNAs were up-regulated in AD, and two miRNAs were down-regulated in PD. Predictive target analysis identified three disease-specific clusters of pathways as a result of platelet-miRNA deregulation. Our cross-sectional study assesses the identification of a novel, highly specific and sensitive platelet-associated miRNA-based biosignature, which distinguishes DLB from AD.
Matèries
Matèries (anglès)
Citació
Citació
GÁMEZ VALERO, Ana, CAMPDELACREU I FUMADÓ, Jaume, VILAS, Dolores, ISPIERTO, Lourdes, GASCÓN-BAYARRI, Jordi, REÑÉ RAMÍREZ, Ramon, ÁLVAREZ, Ramiro, ARMENGOL, Maria p., BORRÀS I SERRES, Francesc enric, BEYER, Katrin. Platelet miRNA Biosignature Discriminates between Dementia with Lewy Bodies and Alzheimer’s Disease. _Biomedicines_. 2021. Vol. 9, núm. 9, pàgs. 1272. [consulta: 21 de gener de 2026]. ISSN: 2227-9059. [Disponible a: https://hdl.handle.net/2445/180503]